Phathom Pharmaceuticals Inc (NASDAQ:PHAT)’s traded shares stood at 1.11 million during the last session, with the company’s beta value hitting 0.68. At the close of trading, the stock’s price was $10.09, to imply a decrease of -0.10% or -$0.01 in intraday trading. The PHAT share’s 52-week high remains $17.02, putting it -68.68% down since that peak but still an impressive 39.84% since price per share fell to its 52-week low of $6.07. The company has a valuation of $590.47M, with an average of 874.77K shares over the past 3 months.

Phathom Pharmaceuticals Inc (NASDAQ:PHAT) trade information

After registering a -0.10% downside in the last session, Phathom Pharmaceuticals Inc (PHAT) has traded red over the past five days. The stock hit a weekly high of 11.24, dropping -0.10% in its intraday price action. The 5-day price performance for the stock is 3.38%, and -14.49% over 30 days. With these gigs, the year-to-date price performance is 10.51%.

Phathom Pharmaceuticals Inc (PHAT) estimates and forecasts

Looking at statistics comparing Phathom Pharmaceuticals Inc share performance against respective industry, we note that the company has underperformed competitors. Phathom Pharmaceuticals Inc (PHAT) shares are 24.26% up over the last 6 months, with its year-to-date growth rate lower than industry average at -113.83% against 13.30%. The rating firms project that company’s revenue will grow 6,435.20% compared to the previous financial year.

Revenue forecast for the current quarter as set by 8 analysts is 2.05M. Meanwhile, for the current quarter, a total of 8 analyst(s) estimate revenue growth to 6.03M.

PHAT Dividends

Phathom Pharmaceuticals Inc has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Phathom Pharmaceuticals Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.